General Catalyst

Founded in 2000, General Catalyst is a venture capital firm specializing in early-stage and growth equity investments. It focuses on accelerating ideas, careers, and companies towards success by providing ongoing momentum and mentorship based on deep experience.

Adrian Abeijon

Investor

Mark Allen

CFO

Samuel Beyer

Investor

Marc Bhargava

Managing Director

Chris Bischoff

Managing Director

Past deals in Health Diagnostics

Sohar Health

Seed Round in 2025
Sohar Health is a technology company that provides an API-based platform for behavioral health organizations. Its key offerings include automated eligibility verification and AI-powered medical coding, aiming to streamline workflows, enhance patient intake, and boost revenue.

Fay

Series B in 2025
Fay connects individuals with dietitians covered by their health insurance, promoting healthier eating habits and lifestyles.

Neko Health

Series B in 2025
Neko Health is a Swedish health-tech company focused on transforming healthcare through prevention and early detection. The company has developed innovative medical scanning technology that facilitates comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By utilizing advanced sensor technology and artificial intelligence, Neko Health aims to enhance preventive care and reduce the incidence of common diseases, thereby lowering associated healthcare costs. This approach enables healthcare providers to deliver flexible and cost-effective examinations, ultimately improving the quality of care and emphasizing the importance of preventive health measures.

Hippocratic AI

Series B in 2025
Hippocratic AI specializes in developing large language models focused on safety and patient-facing applications within the healthcare sector. Unlike common approaches that rely heavily on internet data, Hippocratic AI prioritizes acquiring evidence-based healthcare content legally to ensure accurate and reliable information.

Orange Health Labs

Venture Round in 2024
Orange Health is a health technology company that facilitates remote diagnostic lab services for patients, allowing doctors to provide real-time care. Its platform focuses on patient-centric home sample collection and testing, aiming to make healthcare more accessible and efficient.

Oasys Now

Seed Round in 2024
Oasys Now is a platform dedicated to connecting chronic patients with relevant clinical trials worldwide. It uses advanced algorithms to match patients with appropriate trials based on their health data, enhancing treatment options and prioritizing patient privacy.

Primus

Seed Round in 2024
Primus helps elderly people slow the aging process by eliminating loneliness and achieving 'Zero Falls'. We ensure that we are proactive rather than reactive by conducting a series of examinations prior to onboarding elders so that they can be monitored by our in-house medical staff under a personalized care plan.

Maven Clinic

Series F in 2024
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Better Health

Series A in 2024
Better Health is a digital platform facilitating peer-to-peer support and supplies management for individuals with chronic conditions such as ostomy, wounds, diabetes, retention, and incontinence. Trusted by major healthcare payers and providers, it improves patient outcomes and reduces care costs through education, engagement, and adherence.

Fay

Series A in 2024
Fay connects individuals with dietitians covered by their health insurance, promoting healthier eating habits and lifestyles.

Hona AI

Seed Round in 2024
Hona AI is an AI data platform that collects and maintains healthcare history and records of patients.

Karius

Series C in 2024
Karius is a life sciences company that develops genomic insights for infectious diseases. Its core offering, the Karius Test, is a non-invasive blood test that sequences microbial cell-free DNA to identify and quantify pathogens—including bacteria, DNA viruses, fungi, and parasites—for use in complicated pneumonia, infections in immunocompromised patients, and endocarditis. The company also provides laboratory services for pathogen biomarker detection for biopharmaceutical research and development. Founded in 2014, Karius is headquartered in Redwood City, California, with an additional office in Menlo Park, California. The laboratory operations are CLIA-certified and CAP-accredited, enabling high-complexity clinical testing. By mapping a patient’s microbial landscape from a single blood draw, Karius aims to support rapid, informed treatment decisions.

Hippocratic AI

Series A in 2024
Hippocratic AI specializes in developing large language models focused on safety and patient-facing applications within the healthcare sector. Unlike common approaches that rely heavily on internet data, Hippocratic AI prioritizes acquiring evidence-based healthcare content legally to ensure accurate and reliable information.

Overjet

Series C in 2024
Overjet develops AI-based software for dental clinical data analysis. Founded by experts from MIT and Harvard University, it offers solutions like clinical optimization software for practice performance assessment and utilization software for claims review to ensure appropriate care at lower costs. Its FDA-cleared technology enables precise detection of oral anomalies in X-rays.

Evvy

Series A in 2023
Evvy is a company focused on women's health, specializing in at-home vaginal microbiome tests aimed at closing the gender health gap. By utilizing metagenomic sequencing, Evvy's tests analyze individual symptoms and assess risks related to significant health issues. The company provides personalized reports that empower women with insights into their bodies, facilitating a better understanding of their health and promoting overall well-being.

Neko Health

Series A in 2023
Neko Health is a Swedish health-tech company focused on transforming healthcare through prevention and early detection. The company has developed innovative medical scanning technology that facilitates comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By utilizing advanced sensor technology and artificial intelligence, Neko Health aims to enhance preventive care and reduce the incidence of common diseases, thereby lowering associated healthcare costs. This approach enables healthcare providers to deliver flexible and cost-effective examinations, ultimately improving the quality of care and emphasizing the importance of preventive health measures.

Hippocratic AI

Seed Round in 2023
Hippocratic AI specializes in developing large language models focused on safety and patient-facing applications within the healthcare sector. Unlike common approaches that rely heavily on internet data, Hippocratic AI prioritizes acquiring evidence-based healthcare content legally to ensure accurate and reliable information.

Paradigm

Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare systems by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Breathe Well-being

Series B in 2023
Breathe Well-being is a health technology company based in India. It offers a clinically proven program for individuals with chronic conditions like diabetes, aiming to help them lose weight and manage their health effectively. The program provides one-on-one coaching, tracking of weight, meals, and activity, along with cognitive behavioral therapy techniques to reduce stress.

Fay

Seed Round in 2023
Fay connects individuals with dietitians covered by their health insurance, promoting healthier eating habits and lifestyles.

Disclo

Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

Maven Clinic

Series E in 2022
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Redesign Health

Series C in 2022
Founded in 2018, Redesign Health is a global venture builder empowering founders to launch and scale transformative healthcare companies. Since its inception, it has supported over two dozen companies impacting more than ten million lives across various healthcare sectors.

Homeward

Series B in 2022
Homeward delivers innovative rural health services for over 60 million Americans residing in rural communities. It employs multidisciplinary care teams offering both virtual and on-site care via mobile units, along with remote monitoring to enhance patient connections to high-quality, affordable healthcare.

August Health

Series A in 2022
August Health develops an integrated electronic health record platform for senior living communities. Their technology enables caregivers to shift from reactive to proactive care, offering features like digital move-ins, medication tracking, real-time insights, billing solutions, and mobile daily care tracking.

Examedi

Series A in 2022
Examedi is a healthcare startup that facilitates at-home medical services by connecting patients with independent healthcare providers, including nurses and lab technicians. The company's telemedicine platform allows patients to book diagnostic tests and examinations from the comfort of their homes, focusing on services such as blood tests, pregnancy tests, general check-ups, and COVID-19 testing. By streamlining the scheduling process and offering affordable access to various medical tests, Examedi aims to enhance patient convenience and improve healthcare delivery.

Flexpa

Seed Round in 2022
Founded in 2021, Flexpa is a San Francisco-based company that develops APIs to integrate claims histories into digital health and fintech apps. Its platform also digitizes data from various hardware providers, interprets it, and creates analytics dashboards for healthcare providers to determine treatment plans.

Orange Health Labs

Series B in 2022
Orange Health is a health technology company that facilitates remote diagnostic lab services for patients, allowing doctors to provide real-time care. Its platform focuses on patient-centric home sample collection and testing, aiming to make healthcare more accessible and efficient.

Alinea Health

Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.

Homeward

Series A in 2022
Homeward delivers innovative rural health services for over 60 million Americans residing in rural communities. It employs multidisciplinary care teams offering both virtual and on-site care via mobile units, along with remote monitoring to enhance patient connections to high-quality, affordable healthcare.

Ro

Venture Round in 2022
Ro is a telehealth company founded in New York City in 2017. It operates digital health clinics for men's and women's health, smoking cessation, and offers a vertically integrated primary care platform that provides high-quality, affordable healthcare without the need for insurance.

Casana

Series B in 2022
Casana, officially known as Heart Health Intelligence Inc., is a healthcare technology company based in Rochester, New York, founded in 2018. It specializes in developing innovative solutions for heart health monitoring, primarily through its flagship product, the Heart Seat. This smart toilet seat is designed to facilitate effortless and continuous in-home health monitoring by capturing essential clinical measurements such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation. The Heart Seat integrates advanced sensors, including a single-lead ECG, embedded photoplethysmogram LEDs, and sensitive weight sensors, to monitor cardiac activity. By offering a cloud-connected platform, Casana enables healthcare practitioners to track patients' cardiac health beyond traditional clinical settings, thereby enhancing the management of chronic conditions and improving patient outcomes through reliable and consistent vital signs analysis.

Overjet

Series B in 2021
Overjet develops AI-based software for dental clinical data analysis. Founded by experts from MIT and Harvard University, it offers solutions like clinical optimization software for practice performance assessment and utilization software for claims review to ensure appropriate care at lower costs. Its FDA-cleared technology enables precise detection of oral anomalies in X-rays.

Cadence Solutions

Series B in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.

Shyft

Seed Round in 2021
Shyft is a personalized wellness platform that offers guided nutrition, meditation, and yoga classes. Shyft offers a variety of Yoga based interactive classes and DIY content focused on managing specific conditions across women's health, chronic ailments, everyday wellness, and mental health.

Better Health

Series A in 2021
Better Health is a digital platform facilitating peer-to-peer support and supplies management for individuals with chronic conditions such as ostomy, wounds, diabetes, retention, and incontinence. Trusted by major healthcare payers and providers, it improves patient outcomes and reduces care costs through education, engagement, and adherence.

Sprinter Health

Series A in 2021
Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.

Elemy

Series B in 2021
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in autism care since its launch in April 2020. The company has expanded its services to address a range of developmental and mental health issues, including ADHD, OCD, depression, and social anxiety. Elemy employs a technology-driven care model that modernizes traditional systems by offering in-home and online Applied Behavior Analysis (ABA) services. This approach enhances accessibility and clinical outcomes while reducing costs. The platform features free autism assessments and matches children with therapists to create individualized treatment plans tailored to their specific needs. Elemy's multidisciplinary clinical team oversees an integrated care model, demonstrating significant improvements in behavior for many children.

Orange Health Labs

Series A in 2021
Orange Health is a health technology company that facilitates remote diagnostic lab services for patients, allowing doctors to provide real-time care. Its platform focuses on patient-centric home sample collection and testing, aiming to make healthcare more accessible and efficient.

Overjet

Series A in 2021
Overjet develops AI-based software for dental clinical data analysis. Founded by experts from MIT and Harvard University, it offers solutions like clinical optimization software for practice performance assessment and utilization software for claims review to ensure appropriate care at lower costs. Its FDA-cleared technology enables precise detection of oral anomalies in X-rays.

Breathe Well-being

Series A in 2021
Breathe Well-being is a health technology company based in India. It offers a clinically proven program for individuals with chronic conditions like diabetes, aiming to help them lose weight and manage their health effectively. The program provides one-on-one coaching, tracking of weight, meals, and activity, along with cognitive behavioral therapy techniques to reduce stress.

Athelas

Series B in 2021
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.

Cadence Solutions

Series A in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.

SonderMind

Series C in 2021
SonderMind is a Denver-based digital health company established in 2017, specializing in accessible and approachable mental health services. It operates an online platform that connects individuals with a network of licensed therapists, offering a range of services including video telehealth and in-person sessions. SonderMind focuses on various mental health conditions such as anxiety, depression, ADHD, and PTSD, among others. The company aims to streamline the process of finding and accessing mental health care, ensuring a good match between clients and therapists, while also supporting therapists by handling administrative and billing tasks.

Evvy

Seed Round in 2021
Evvy is a company focused on women's health, specializing in at-home vaginal microbiome tests aimed at closing the gender health gap. By utilizing metagenomic sequencing, Evvy's tests analyze individual symptoms and assess risks related to significant health issues. The company provides personalized reports that empower women with insights into their bodies, facilitating a better understanding of their health and promoting overall well-being.

Osana

Series A in 2021
Osana is a healthtech company offering an omnichannel platform focused on patient-centric care. This platform aims to optimize resource usage by providing services such as clinical analysis, emergency ambulance services, video consultations, and data-driven insights.

Terra API

Seed Round in 2021
Terra facilitates seamless health data exchange. It connects applications with various wearables, sensors, and blood labs.

Tempo

Series C in 2021
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Ro

Series D in 2021
Ro is a telehealth company founded in New York City in 2017. It operates digital health clinics for men's and women's health, smoking cessation, and offers a vertically integrated primary care platform that provides high-quality, affordable healthcare without the need for insurance.

Elemy

Series A in 2021
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in autism care since its launch in April 2020. The company has expanded its services to address a range of developmental and mental health issues, including ADHD, OCD, depression, and social anxiety. Elemy employs a technology-driven care model that modernizes traditional systems by offering in-home and online Applied Behavior Analysis (ABA) services. This approach enhances accessibility and clinical outcomes while reducing costs. The platform features free autism assessments and matches children with therapists to create individualized treatment plans tailored to their specific needs. Elemy's multidisciplinary clinical team oversees an integrated care model, demonstrating significant improvements in behavior for many children.

ixLayer

Series A in 2021
ixLayer is a leader in the health-tech sector, specializing in precision health testing solutions that facilitate virtual health testing for various stakeholders, including health systems, payors, biopharma, and health-focused organizations. Established in 2018, ixLayer's platform offers comprehensive solutions encompassing technical, security, regulatory, and user experience aspects of complex health testing. As the demand for remote and virtual care continues to grow, ixLayer enhances patient engagement and preventative health strategies by enabling real-time health and wellness lab testing. The platform can be seamlessly integrated with existing patient engagement systems and portals, allowing organizations to efficiently launch and manage testing programs. Serving millions of patients, ixLayer has developed and implemented numerous testing initiatives for large organizations, healthcare systems, and government agencies, contributing to a progressive shift towards telehealth.

Sprinter Health

Seed Round in 2021
Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.

Truvian Sciences

Series C in 2021
Truvian Sciences Inc. is a diagnostic company based in San Diego, California, focused on revolutionizing the blood testing industry. Incorporated in 2015, the company has developed an automated benchtop system that delivers lab-accurate results for a variety of health tests. Its comprehensive wellness panel includes commonly ordered routine blood tests such as complete blood count, metabolic panel, and lipid panel, all from a single sample. Additionally, Truvian's software system enables healthcare practitioners to efficiently deliver test results to patients through a user-friendly platform.

Casana

Series A in 2021
Casana, officially known as Heart Health Intelligence Inc., is a healthcare technology company based in Rochester, New York, founded in 2018. It specializes in developing innovative solutions for heart health monitoring, primarily through its flagship product, the Heart Seat. This smart toilet seat is designed to facilitate effortless and continuous in-home health monitoring by capturing essential clinical measurements such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation. The Heart Seat integrates advanced sensors, including a single-lead ECG, embedded photoplethysmogram LEDs, and sensitive weight sensors, to monitor cardiac activity. By offering a cloud-connected platform, Casana enables healthcare practitioners to track patients' cardiac health beyond traditional clinical settings, thereby enhancing the management of chronic conditions and improving patient outcomes through reliable and consistent vital signs analysis.

Elephant Healthcare

Series A in 2021
Founded by doctors in 2018, Elephant Healthcare is a London-based technology company dedicated to addressing global healthcare challenges. It designs and develops a digital health system that aims to connect all aspects of the healthcare ecosystem, transforming primary care, saving lives, and reducing costs.

Curai Health

Series B in 2020
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company specializes in providing affordable primary care through a chat-based interface that integrates artificial intelligence with human clinicians. This approach leverages advanced machine learning tools to streamline patient interactions and enhance diagnostic accuracy. By creating a responsive learning healthcare system, Curai Health aims to make high-quality primary care accessible to everyone, reducing the overall cost of care delivery. The service is available directly to consumers and can also be accessed through enterprise partnerships, emphasizing its commitment to improving healthcare accessibility and affordability.

Tempo

Series B in 2020
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Ro

Series C in 2020
Ro is a telehealth company founded in New York City in 2017. It operates digital health clinics for men's and women's health, smoking cessation, and offers a vertically integrated primary care platform that provides high-quality, affordable healthcare without the need for insurance.

Elemy

Seed Round in 2020
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in autism care since its launch in April 2020. The company has expanded its services to address a range of developmental and mental health issues, including ADHD, OCD, depression, and social anxiety. Elemy employs a technology-driven care model that modernizes traditional systems by offering in-home and online Applied Behavior Analysis (ABA) services. This approach enhances accessibility and clinical outcomes while reducing costs. The platform features free autism assessments and matches children with therapists to create individualized treatment plans tailored to their specific needs. Elemy's multidisciplinary clinical team oversees an integrated care model, demonstrating significant improvements in behavior for many children.

SonderMind

Series B in 2020
SonderMind is a Denver-based digital health company established in 2017, specializing in accessible and approachable mental health services. It operates an online platform that connects individuals with a network of licensed therapists, offering a range of services including video telehealth and in-person sessions. SonderMind focuses on various mental health conditions such as anxiety, depression, ADHD, and PTSD, among others. The company aims to streamline the process of finding and accessing mental health care, ensuring a good match between clients and therapists, while also supporting therapists by handling administrative and billing tasks.

Karius

Series B in 2020
Karius is a life sciences company that develops genomic insights for infectious diseases. Its core offering, the Karius Test, is a non-invasive blood test that sequences microbial cell-free DNA to identify and quantify pathogens—including bacteria, DNA viruses, fungi, and parasites—for use in complicated pneumonia, infections in immunocompromised patients, and endocarditis. The company also provides laboratory services for pathogen biomarker detection for biopharmaceutical research and development. Founded in 2014, Karius is headquartered in Redwood City, California, with an additional office in Menlo Park, California. The laboratory operations are CLIA-certified and CAP-accredited, enabling high-complexity clinical testing. By mapping a patient’s microbial landscape from a single blood draw, Karius aims to support rapid, informed treatment decisions.

Elysium

Series C in 2019
Elysium Health, Inc., established in 2014 and headquartered in New York, specializes in the development and sale of health supplements. The company focuses on two primary areas: cellular health and optimization, and long-term brain health. It offers a proprietary formulation of natural compounds, designed to support overall well-being at the cellular level, which is sold directly to consumers via its online platform. Additionally, Elysium provides a biological age testing solution.

Curai Health

Series A in 2018
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company specializes in providing affordable primary care through a chat-based interface that integrates artificial intelligence with human clinicians. This approach leverages advanced machine learning tools to streamline patient interactions and enhance diagnostic accuracy. By creating a responsive learning healthcare system, Curai Health aims to make high-quality primary care accessible to everyone, reducing the overall cost of care delivery. The service is available directly to consumers and can also be accessed through enterprise partnerships, emphasizing its commitment to improving healthcare accessibility and affordability.

Ro

Seed Round in 2017
Ro is a telehealth company founded in New York City in 2017. It operates digital health clinics for men's and women's health, smoking cessation, and offers a vertically integrated primary care platform that provides high-quality, affordable healthcare without the need for insurance.

Elysium

Series B in 2016
Elysium Health, Inc., established in 2014 and headquartered in New York, specializes in the development and sale of health supplements. The company focuses on two primary areas: cellular health and optimization, and long-term brain health. It offers a proprietary formulation of natural compounds, designed to support overall well-being at the cellular level, which is sold directly to consumers via its online platform. Additionally, Elysium provides a biological age testing solution.

TearScience

Series D in 2016
TearScience, Inc. is a medical device company based in Morrisville, North Carolina, specializing in the identification, diagnosis, and treatment of meibomian gland disease (MGD), a primary cause of dry eye affecting millions worldwide. Founded in 2005, TearScience has developed innovative devices to address evaporative dry eye, including the LipiFlow Activator, which delivers automated therapeutic energies to treat the meibomian glands, and the LipiScan, an imaging tool that allows eye care professionals to assess gland health. The company's integrated system enables effective management of MGD, which is often underestimated despite being a leading contributor to dry eye symptoms such as irritation, dryness, and visual disturbances. As a subsidiary of Johnson & Johnson Surgical Vision, TearScience continues to advance its mission of improving patient outcomes through early detection and treatment of this chronic condition.

Oceans Healthcare

Venture Round in 2013
Oceans Healthcare is a behavioral health provider established in 2004, dedicated to healing and long-term recovery for individuals, particularly older adults. The company operates 33 locations, including 23 inpatient hospital campuses across the Southeast, and specializes in addressing cognitive and mental health symptoms such as depression, anxiety, and schizophrenia, as well as behavioral changes related to medication management and substance abuse. In 2020, Oceans treated over 18,000 individuals, demonstrating a commitment to comprehensive care throughout the recovery process. The company is recognized for its consistent achievement of high performance metrics on national quality and safety measurements, as assessed by the Centers for Medicare and Medicaid Services and The Joint Commission. Additionally, Oceans Healthcare has earned a place on the Inc. 5000 list of the fastest-growing private companies in America for four consecutive years.

SynapDx

Series B in 2012
SynapDx is a diagnostic company based in Lexington, Massachusetts, focused on providing laboratory testing services aimed at the early detection of autism spectrum disorders (ASDs) in children. Established by Stanley Lapidus, the company develops blood-based diagnostic tests that leverage insights from experts in ASD and gene expression. These tests are designed to assist healthcare providers in identifying early symptoms of autism, addressing the need for timely intervention in a condition that affects approximately 1 in 110 children in the United States. Through its innovative approach, SynapDx aims to enhance the diagnostic process for developmental disorders and improve outcomes for affected children and their families.

SynapDx

Series A in 2010
SynapDx is a diagnostic company based in Lexington, Massachusetts, focused on providing laboratory testing services aimed at the early detection of autism spectrum disorders (ASDs) in children. Established by Stanley Lapidus, the company develops blood-based diagnostic tests that leverage insights from experts in ASD and gene expression. These tests are designed to assist healthcare providers in identifying early symptoms of autism, addressing the need for timely intervention in a condition that affects approximately 1 in 110 children in the United States. Through its innovative approach, SynapDx aims to enhance the diagnostic process for developmental disorders and improve outcomes for affected children and their families.

TearScience

Series C in 2010
TearScience, Inc. is a medical device company based in Morrisville, North Carolina, specializing in the identification, diagnosis, and treatment of meibomian gland disease (MGD), a primary cause of dry eye affecting millions worldwide. Founded in 2005, TearScience has developed innovative devices to address evaporative dry eye, including the LipiFlow Activator, which delivers automated therapeutic energies to treat the meibomian glands, and the LipiScan, an imaging tool that allows eye care professionals to assess gland health. The company's integrated system enables effective management of MGD, which is often underestimated despite being a leading contributor to dry eye symptoms such as irritation, dryness, and visual disturbances. As a subsidiary of Johnson & Johnson Surgical Vision, TearScience continues to advance its mission of improving patient outcomes through early detection and treatment of this chronic condition.

Sprinter Health

Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.